Pb BCY20603
Alternative Names: Pb-BCY20603Latest Information Update: 30 Jun 2023
At a glance
- Originator Bicycle Therapeutics; Orano Med
- Class Antineoplastics; Bicyclic peptide drug conjugates; Lead radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer